On November 11, ST Zhongzhu became "one yuan shares". As of the afternoon closing, ST Zhongzhu reported to 1.52 yuan/share, an increase of 3.4%, with a total market value of 3.09 billion yuan.
According to the relevant provisions of the "Stock Listing Rules", listed companies that issue A shares will be issued by the companys stocks for 20 consecutive trading days.It was terminated and traded.In addition, the companys shares will not enter the delisting period due to the touches of the trading mandatory delisting situation.
Data show that Zhongzhu Medical Holdings Co., Ltd. was formerly known as Hubei Qianjiang Pharmaceutical Co., Ltd., and was listed on the Shanghai Exchange on May 18, 2001 (stock code: 600568)It is a national ophthalmological drug production base and an ophthalmological pharmaceutical listed company.In recent years, the company has the courage to explore and practice in the medical field, and has established the strategy of assisting reproductive, stem cell applications, tumor diagnosis and treatment equipment, tumor diagnosis and rehabilitation strategy to comprehensively march in the strategy of comprehensively marching.Objectives, business throughout the three major areas of medical, medicine, and medical skills, through the integration of resources, the rapid development of enterprises has been achieved.
Financial data shows that in the third quarter of 2022, 2023, and 2024, the net profit attributable to ST Zhongzhu was -799 million yuan, -344 million yuan, and -924.185 million yuan, respectively.
As of September 30, 2024, the number of shareholders of ST Zhongzhu was 20,700, and the per capita shareholding amount was 108,200 yuan, and the chips were concentrated.
This article comes from: the financial industry
Author: market
